Mehta Vimal 4
4 · BioXcel Therapeutics, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Mehta Vimal
DirectorCEO and President
Transactions
- Award
Restricted Stock Units
2026-01-01+199,032→ 200,783 total→ Common Stock (199,032 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]On January 1, 2026, the Reporting Person was granted 199,032 RSUs, vesting as to 25% of the underlying shares on the six-month anniversary of the original promise date of November 4, 2025 (the "Vesting Commencement Date"), with the remaining 75% vesting in three equal installments of 25% on the last day of each subsequent six-month period thereafter, such that the RSUs are fully vested on the two-year anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.